$43.61 $0.48 per serving
Product analysis
Kyolic Omega-3 provides EPA and DHA for heart-related nutritional support. Their amounts are below the larger exposures behind the lipid findings, so the practical effect may be limited.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality21
The EPA and DHA preparation details are unspecified, limiting comparisons between sources. The garlic preparation also lacks the detail needed for a source-quality judgment.
Ingredient Transparency58
EPA and DHA are separately quantified, helping you compare the main active amounts. The vitamin E amount and part of the mixture breakdown remain unclear.
Value For Money64
EPA compares favorably for cost, while DHA offers a more moderate value contribution. Garlic value cannot be judged reliably.
Customer Satisfaction87
Customer ratings show very favorable satisfaction. A substantial number of ratings makes buyer opinion more established.
Product Focus68
EPA and DHA give the formula a clear cardiovascular focus, with more limited brain-related support. Their nutritional roles do not imply an immediate improvement in concentration.
- Format
Softgel - Container
- 180 Softgel(s)
- Per serving
- $0.48
- Also available
Kyolic Omega-3$24.71- Customer rating
- 4.8 · 1,913 ratings
Goals
Impact
Moderate effect
Fish Oil · 2000 mgVitamin E · 10 IU
EPA and DHA may lower some blood markers of inflammation. A change in those markers does not necessarily mean you’ll notice symptom relief or receive a broad anti-inflammatory benefit. The declared EPA and DHA amounts matter more for this connection than the total weight of fish oil.
How this product is rated for Inflammation
Ingredient fit58
EPA and DHA may lower inflammatory blood markers; symptom relief is a separate outcome.
Goal fit
EPA and DHA may lower inflammatory blood markers; symptom relief is a separate outcome.
Dose adequacy
One serving supplies 400 mg of DHA (docosahexaenoic acid); the numerical comparison alone does not demonstrate an anti-inflammatory effect.
Pathways16
EPA and DHA may lower inflammatory blood markers; symptom relief is a separate outcome.
Depth
EPA and DHA may lower inflammatory blood markers; symptom relief is a separate outcome.
Breadth
The described ingredient roles do not imply broad relief across different inflammatory conditions.
Evidence70
EPA and DHA may lower inflammatory blood markers; symptom relief is a separate outcome.
Evidence strength
EPA and DHA may lower inflammatory blood markers; symptom relief is a separate outcome.
Studied preparation
The relevant ingredient preparations permit comparison, but that does not guarantee a practical anti-inflammatory benefit.
Formulation logic92
No additional partner is required for the described roles, and no particular ingredient conflict is identified.
Partner coverage
No additional partner is required for the described ingredient roles.
Conflicts
No particular ingredient conflict is identified.
Effective doses
Some amounts do not reach lower comparisons: Vitamin E. This is not proof of ineffectiveness.
Impact
High effect
EPA (Eicosapentaenoic Acid) · 600 mg
EPA is linked mainly to triglyceride-related support, while DHA has more limited lipid and vascular evidence. Their separately declared amounts establish active content, unlike total fish-oil mass. Routine supplementation has not established prevention of major cardiovascular events, and prescription EPA findings in selected high-risk patients do not transfer to this product. The two fats do not imply an extra benefit from their combination.
How this product is rated for Heart Health
Ingredient fit68
EPA and DHA provide the main recognized connection. EPA and DHA provide partial exposure coverage in the saved comparison, without establishing a proven effective dose.
Goal fit
EPA and DHA are the main recognized focus. Other actives broaden the formula beyond these heart-related roles.
Dose adequacy
EPA and DHA provide partial exposure coverage in the saved comparison, without establishing a proven effective dose.
Pathways56
The findings center on triglyceride handling, with narrow coverage across the evaluated functions.
Depth
The main recognized connection is triglyceride handling.
Breadth
The breadth finding centers on triglyceride handling, rather than broad coverage of different heart-health functions.
Evidence100
EPA supplies the strongest evidence finding here, chiefly for triglyceride support rather than routine event prevention.
Evidence strength
EPA supplies the strongest evidence finding here, chiefly for triglyceride support rather than routine event prevention.
Studied preparation
The saved preparation check recognizes the counted declarations; this does not establish product-specific trial results.
Formulation logic100
EPA and DHA have no identified required-partner gap or configured conflict. All ingredients counted for this check meet its minimum exposure criterion; that criterion is not proof of clinical benefit.
Partner coverage
No missing required partner was identified among the counted ingredients; this does not establish added benefit from combining them.
Conflicts
No configured ingredient conflict was identified in the supplied facts.
Effective doses
All ingredients counted for this check meet its minimum exposure criterion; that criterion is not proof of clinical benefit.
DHA (Docosahexaenoic Acid) Not classified
No linked studies yet.
Impact
High effect
Fish Oil · 2000 mgVitamin E · 10 IU
EPA and DHA contribute to triglyceride lowering, with the supplied studies using larger daily amounts of each fatty acid than this serving’s 600 mg EPA and 400 mg DHA. The separate declarations support a limited exposure comparison without inferring a combined fish-oil active amount. Their lipid-marker role does not establish prevention of cardiovascular events, and the unknown vitamin E amount adds no established cardiovascular benefit.
How this product is rated for Cardiovascular Support
Ingredient fit73
Relevant cardiovascular ingredients sit within a broader formula with other purposes. The declared amounts provide varying exposure to relevant ingredients; comparison with study amounts does not establish a daily regimen.
Goal fit
Relevant cardiovascular ingredients sit within a broader formula with other purposes.
Dose adequacy
The declared amounts provide varying exposure to relevant ingredients; comparison with study amounts does not establish a daily regimen.
Pathways60
Triglyceride metabolism is the strongest represented area, with benefit expectations limited to the supplied lipid-marker findings.
Depth
Triglyceride metabolism is the strongest represented area, with benefit expectations limited to the supplied lipid-marker findings.
Breadth
One cardiovascular area meets the saved coverage threshold, so the support is concentrated rather than broad.
Evidence83
EPA supports a triglyceride-marker role; the supplied evidence does not establish cardiovascular-event prevention.
Evidence strength
EPA supports a triglyceride-marker role; the supplied evidence does not establish cardiovascular-event prevention.
Studied preparation
The saved preparation comparison accepts the qualifying ingredients, but that finding does not extend the evidence beyond the populations and outcomes described.
Formulation logic92
The qualifying ingredients have no missing required partners or matched conflicts in the supplied checks.
Partner coverage
No required partner is missing for the credited ingredients; this does not establish an extra benefit from combining them.
Conflicts
No matching formulation conflict was identified in the supplied checks.
Effective doses
The other qualifying ingredients meet the saved amount threshold; vitamin E’s unresolved amount does not.
Impact
Moderate effect
DHA and EPA contribute to brain-related nutritional support. The serving provides 400 mg DHA and 600 mg EPA, while the supplied evidence concerns repeated intake and does not support expecting an immediate improvement in focus.
How this product is rated for Mental Focus
Ingredient fit63
Focus-related ingredients sit within a formula serving broader purposes. The assessed quantities provide a meaningful but incomplete match to the saved benchmarks.
Goal fit
Focus-related ingredients sit within a formula serving broader purposes.
Dose adequacy
The assessed quantities provide a meaningful but incomplete match to the saved benchmarks.
Pathways50
The main recorded contribution relates to brain-cell maintenance and signalling. One main mechanism meets the saved coverage benchmark, so support is relatively focused.
Depth
The main recorded contribution relates to brain-cell maintenance and signalling.
Breadth
One main mechanism meets the saved coverage benchmark, so support is relatively focused.
Evidence56
EPA (Eicosapentaenoic Acid) provides the strongest evidence contribution among the assessed ingredients. EPA matches a studied preparation in the saved assessment; DHA does not.
Evidence strength
EPA (Eicosapentaenoic Acid) provides the strongest evidence contribution among the assessed ingredients.
Studied preparation
EPA matches a studied preparation in the saved assessment; DHA does not.
Formulation logic100
The assessed ingredients can contribute independently or have their required partners. No ingredient conflict was flagged by the saved checks.
Partner coverage
The assessed ingredients can contribute independently or have their required partners.
Conflicts
No ingredient conflict was flagged by the saved checks.
Effective doses
All counted ingredients meet the saved minimum amount threshold.
DHA (Docosahexaenoic Acid) Not classified
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin E (D-Alpha-Tocopherol) | 10 IU | |
Omega-3 Fish Oil concentrate | 2000 mg | |
Eicosapentaenoic Acid | 600 mg | |
Docosahexaenoic Acid | 400 mg | |
Aged Garlic extract powder | 240 mg |
EPA (Eicosapentaenoic Acid) · 600 mg OverallScore69
A serving provides 600 mg of EPA and 400 mg of DHA, giving it more EPA than DHA. Its EPA costs about $0.81 per gram.
How this ingredient is rated
Active Ingredient Quality & Bioavailability50
The EPA molecular form is unresolved in the available information. EPA is only part of the stated fish oil amount.
Molecular Form and Bioavailability
The available information does not establish the molecular form; an ethyl ester form cannot be assumed.
EPA Concentration Density
EPA makes up about 30% of the stated fish oil amount per serving.
Oxidation Protection
Tocopherols are included; their presence does not measure the oil’s freshness.
Dose, Safety & Label Transparency82
The serving provides 600 mg EPA and 400 mg DHA.
Absolute EPA Dose per Serving
Each serving provides 600 mg of EPA.
EPA-Centric Ratio
The serving has 600 mg of EPA and 400 mg of DHA, so it contains more EPA than DHA.
Purity and Contaminant Testing
The oil is described as purified, but the saved evaluation does not establish a qualifying contaminant-specific testing or certification claim.
Value80
At about $0.81 per gram of EPA, the EPA cost is relatively low in this comparison.
Price per Gram of EPA
The estimate uses the stated EPA amount and price per whole-product serving.
Vitamin E (D-Alpha-Tocopherol) · 10 IU OverallScore44
Fish Oil · 2000 mg OverallScore63
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
- Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
- A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
- Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
- Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- Supplementation with vitamin E alone is associated with reduced myocardial infarction: a meta-analysis.
- Vitamin E ameliorates blood cholesterol level and alters gut microbiota composition: A randomized controlled trial.
- Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
- Independent and combined associations of dietary antioxidant exposure with all-cause and cause-specific mortality in the general population.
- Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: A randomized controlled study.
- Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
- Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
- Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
- Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
- Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
- Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
- Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
- Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
- The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
- Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.